Thermal biofeedback for primary Raynaud's phenomenon: a review of the literature

Applied Psychophysiology Biofeedback

Volumn 31, Issue 3, 2006, Pages 203-216

  Karavidas, Maria Katsamanis ^a   Tsai, Pei Shan ^b   Yucha, Carolyn ^c   McGrady, Angele ^d   Lehrer, Paul M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NEVADA   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Primary Raynaud's phenomenon; Thermal biofeedback

Indexed keywords

NIFEDIPINE; PLACEBO;

ELECTROMYOGRAPHY; HUMAN; LEISURE; MEDICAL LITERATURE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PSYCHOPHYSIOLOGY; RAYNAUD PHENOMENON; REVIEW; TEMPERATURE; TREATMENT OUTCOME;

BIOFEEDBACK (PSYCHOLOGY); CLINICAL TRIALS; GUIDELINES; HUMANS; RAYNAUD DISEASE;

EID: 33750292636     PISSN: 10900586     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10484-006-9018-2     Document Type: Review

References (34)

1. Allen, E. V., & Brown, G. E. (1932). Raynaud's disease: a critical review of minimal requisites for diagnosis. American Journal of Medical Science, 183, 187-200.
2. Block, J. A., & Sequeira, W. (2001). Raynaud's phenomenon. The Lancet, 357, 2042-2048.
3. Cattell, R. B. (1957). IPAT anxiety scale. Institute for Personality and Ability Testing, Champaign, IL.
4. Coffman, J. D. (1991). Raynaud's phenomenon. Hypertension, 17, 593-602.
5. Freedman, R. R., & Ianni, P. (1983). Role of cold and emotional stress in Raynaud's disease and scleroderma. British Medical Journal, 287, 1499-1502.
6. Freedman, R. R., Ianni, P., & Wenig, P. (1985). Behavioral treatment of Raynaud's disease: Long-term follow-up. Journal of Consulting and Clinical Psychology, 53, 136.
7. Freedman, R. R., Sabharwal, S. G., Ianni, P., Desai, N., Wenig, P., & Mayes, M. (1988). Nonneural beta-adrenergic vasodilating mechanism in temperature biofeedback. Psychosomatic Medicine, 50, 394-401.
8. Freedman, R. R., Moten, M., Migaly, P., & Mayes, M. (1993). Cold-induced potentiation of a2-adrenergic vasoconstriction in idiopathic Raynaud's disease. Arthritis and Rheumatism, 36, 685-690.
9. Gardner-Medwin, J. M., Macdonald, I. A., Taylor, J. Y., Riley, P. H., & Powell, R. J. (2001). Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon. British journal of Clinical Pharmacology, 52, 17-23.
10. Graafsma, S. J., Wollersheim, H., Droste, H. T., ten Dam, M. A. G. J., van Tits, L. J. H., Reyenga, J., de Miranda, J. F. R., & Thien, T. (1991). Adrenoreceptors on blood cells from patients with primary Raynaud's phenomenon. Clinical Science, 80, 325-331.
11. Guglielmi, R. S., Roberts, A. H., & Patterson, R. (1982). Skin temperature biofeedback for Raynaud's disease: A double-blind study. Biofeedback and Self-Regulation, 7, 99-120.
12. Jacobson, A. M., Manschreck, T. C., & Silverberg, E. (1979). Behavioral treatment for Raynaud's disease: A comparative study with long-term follow-up. American Journal of Psychiatry, 136, 844-846.
13. Jennings, J. R., Maricq, H. R., Canner, J., Thompson, B., Freedman, R. R., Wise, R., et al. (1999). A thermal vascular test for distinguishing between patients with Raynaud's phenomenon and healthy controls. Raynaud's Treatment Study Investigators. Health Psychology, 18, 421-426.
14. Jobe, J. B., Sampson, J. B., Roberts, D. E., & Kelly, J. A. (1986). Comparison of behavioral treatment for Raynaud's disease. Journal of Behavioral Medicine, 9, 89-96.
15. Keefe, F. J., Surwit, R. S., & Pilon, R. N. (1979). A 1-year follow-up of Raynaud's patients treated with behavioral therapy techniques. Journal of Behavioral Medicine, 2, 385-391.
16. Keefe, F. J., Surwit, R. S., & Pilon, R. N. (1980). Biofeedback, autogenic training, and progressive relaxation in the treatment of Raynaud's disease: A comparative study. Journal of Applied Behavior Analysis, 13, 3-11.
17. La Vaque, T. J., Corrydon, H., Trudeau, D., Monastra, V., Perry, J., Lehrer, P., et al. (2002). Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological interventions. Applied Psychophysiology and Biofeedback, 27(4), 273-281.
18. LeRoy, E. C., & Medsger, T. A. (1992). Raynaud's phenomenon: A proposal for classification. Clinical and Experimental Rheumatology, 10, 485-488.
19. Maricq, H. R., Jennings, J. R., Valter, I., Frederick, M., Thompson, B., Smith, E. A., et al. (2000). Evaluation of treatment efficacy of Raynaud phenomenon by digital blood pressure response to cooling. Raynaud's Treatment Study Investigators. Vascular Medicine, 5, 135-140.
20. Maricq, H. R., Valter, I., & Maricq, J. G. (1998). An objective method to estimate the severity of Raynaud phenomenon: Digital blood pressure response to cooling. Vascular Medicine, 3, 109-113.
21. Middaugh, S. J., Haythornthwaite, J. A., Thompson, B., Hill, R., Brown, K. M., Freedman, R. R., et al. (2001). The Raynaud's treatment study: Biofeedback protocols and acquisition of temperature biofeedback skills. Applied Psychophysiology and Biofeedback, 26, 251-278.
22. Raynaud's Treatment Study (RTS) Investigators. (2000). Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Archives of Internal Medicine, 160, 1101-1108.
23. Robinson, M. E., Gagnon, C. M., Riley, J. L., & Price, D. D. (2003). Altering gender role expectations: effects on pain tolerance, pain threshold, and pain ratings. Journal of Pain, 4, 284-288.
24. Schwartz, M. S., & Sedlacek, K. (2003). Raynaud's disease: selected issues and considerations in using biofeedback therapies. In M. S. Schwartz, & F. Andrasik (Eds.), Biofeedback: a practitioner's guide (3rd ed.). (pp. 369-381). NY: The Guilford Press.
25. Sedlacek, K. (1979). Biofeedback for Raynaud's disease. Psychosomatics, 20, 535-541.
26. Sedlacek, K., & Taub, E. (1996). Biofeedback treatment of Raynaud's disease. Professional Psychology: Research and Practice, 27, 548-553.
27. Simlan, A., Holligan, S., Brennan, P., & Maddison, P. (1990). Prevalence of symptoms of Raynaud's phenomenon in general practice. British Medical Journal, 301, 590-592.
28. Surwit, R. S., Pilon, R. N., & Fenton, C. H. (1978). Behavioral treatment of Raynaud's disease. Journal of Behavioral Medicine, 1, 323-335.
29. Taub, E., & School, P. J. (1978). Some methodological considerations in thermal biofeedback training. Behavior Research Methods and Instrumentation, 10(5), 617-622.
30. Taub, E., & Stroebel, C. F. (1978). Biofeedback in the treatment of vasoconstrictive syndromes. Biofeedback and Self Regulation, 3(4), 363-373.
31. Thompson, B., Geller, N. L., Hunsberger, S., Frederick, M., Hill, R., Jacob, R. G., et al. (1999). Behavioral and pharmacological interventions: The Raynaud's treatment study. Controlled Clinical Trials, 20, 52-63.
32. Turton, E. P. L., Kent, P. J., & Kester, R. C. (1998). The etiology of Raynaud's phenomenon. Cardiovascular Surgery, 6, 431-440.
33. Weinrich, M. C., Maricq, H. R., Keil, J. E., McGregor, A. R., & Diat, F. (1990). Prevalence of Raynaud's phenomenon in the adult population of South Carolina. Journal of Clinical Epidemiology, 43, 1343-1349.
34. Wigley, F. M. (2002). Raynaud's phenomenon. New England Journal Medicine, 347, 1001